肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1236-1242.

• 肝纤维化及肝硬化 • 上一篇    下一篇

淋巴细胞与单核细胞比值对危重症肝硬化预后的预测价值:基于MIMIC数据库

申文娟, 杨力, 罗亮   

  1. 518107 深圳 中山大学附属第七医院重症医学科
  • 收稿日期:2025-09-30 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 罗亮,Email: luoliang@mail.sysu.edu.cn
  • 基金资助:
    深圳市科技计划项目(JCYJ20220818102017035)

The predictive value of lymphocyte-to-monocyte ratio in the prognosis of critically ill patients with liver cirrhosis based on the MIMIC database

Shen Wenjuan, Yang Li, Luo Liang   

  1. Department of Critical Care Medicine, the Seventh Affiliated Hospital of Sun Yat-sen University,Shenzhen 518107, China
  • Received:2025-09-30 Online:2026-09-30 Published:2026-11-16
  • Contact: Luo Liang,Email: luoliang@mail.sysu.edu.cn

摘要: 目的 旨在探讨淋巴细胞与单核细胞比值(LMR)对ICU肝硬化患者28 d死亡风险的影响及其临床意义,以优化患者的风险分层与个体化干预策略。方法 回顾性分析MIMIC-Ⅳ 2.0数据库中1 680例危重症肝硬化患者。收集所有患者的临床病历资料,包括人口统计学特征、临床参数、实验室指标、临床评分,计算患者转入ICU 24 h内的LMR。比较不同LMR水平对患者预后的影响,并通过曲线拟合分析评估LMR与28 d死亡风险的关联性。结果 根据最佳截断值将患者分组,ICU肝硬化患者低LMR(LMR<1.19)组28 d死亡率明显高于高LMR组(LMR≥1.19)(39.2% 比 23.1%),低LMR组脓毒症及AKI发生率明显高于高LMR组,分别为82.5%比70.7%、77.2% 比 65.4%。生存组患者的LMR水平高于死亡组(2.68 比 2.12;P<0.001)。多变量logistic回归分析显示,在调整性别、年龄、总胆红素、白蛋白、肌酐、INR、CCI评分等混杂变量后,按截断值分组,以LMR<1.19为参照,LMR≥1.19与28 d死亡率显著降低相关[OR(95%CI):0.69(0.52~0.92),P=0.01];以LMR<1.27分组,LMR1.27~2.50组、LMR>2.50组与ICU肝硬化患者死亡率降低有关,OR(95%CI)分别为0.71 (0.56~0.89)、0.70 (0.54~0.90)。受限立方样条分析提示LMR与28 d死亡风险呈线性关系,随着LMR升高,保护效应趋于饱和。结论 LMR是危重症肝硬化患者28 d死亡的独立预测指标,且随着LMR升高,死亡风险呈剂量反应关系,提示其在风险分层与干预决策中具有重要应用价值。

关键词: 淋巴细胞单核细胞比值, 危重症, 肝硬化, 炎症标志物, 预后

Abstract: Objective To explore the impact and clinical significance of the lymphocyte-to-monocyte ratio (LMR) on 28-day mortality in cirrhotic patients in the ICU. Methods A retrospective analysis was conducted using data from 1,680 critically ill cirrhotic patients in the MIMIC-IV 2.0 database. Demographic information, clinical parameters, laboratory results, and clinical scores were collected. The LMR within 24 hours of ICU admission was calculated. All the patients were stratified into a low LMR group and a high LMR group based on the optimal cutoff value of LMR. The prognostic impact of LMR on 28-day mortality was assessed, and curve fitting analyses were performed to further explore the relationship between LMR and mortality. Results Among ICU patients with liver cirrhosis, the 28-day mortality rate was significantly higher in the low LMR group (LMR < 1.19) compared to that of the high LMR group (LMR ≥ 1.19) (39.2% vs. 23.1%). The incidence of sepsis and acute kidney injury (AKI) was also significantly higher in the low LMR group than that in the high LMR group (82.5% vs. 70.7% for sepsis; 77.2% vs. 65.4% for AKI). The survivors had higher LMR levels than non-survivors (2.68 vs. 2.12; P<0.001). By multivariate logistic regression analysis, after adjusting for potential confounders including sex, age, total bilirubin, albumin, creatinine, INR, and CCI score, it was showed that LMR ≥ 1.19 was associated with reduced 28-day mortality [OR (95% CI): 0.69 (0.52~0.92), P=0.01] when compared with LMR < 1.19. When grouped by tertiles, both the LMR 1.27~2.50 group and the LMR > 2.50 group were associated with decreased ICU mortality in cirrhotic patients [OR (95% CI) = 0.71 (0.56~0.89) and 0.70 (0.54~0.90)]. Conclusion The lymphocyte-to-monocyte ratio (LMR) is an independent predictor for 28-day mortality in critically ill patients with liver cirrhosis. Furthermore, a dose-response relationship was shown between LMR levels and the mortality risks, indicating a significant application value of LMR level in the risk stratification and decision-making intervention.

Key words: Lymphocyte-to-monocyte ratio, Critical illness, Liver cirrhosis, Inflammatory marker, Prognosis